LXR-623

• Description :

  A clinically viable, highly brain-penetrant LXRα-partial/LXRβ-full agonist with binding Ki of 33 nM/248 nM.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  422.7784

• Molecular Formula :

  C21H12ClF5N2

• Notes :

  Research use only, not for human use.

• Receptor :

  LXRα|LXRβ

• CAS Number :

  875787-07-8